BioTime acquiring substantially all of Cell Targeting's assets for $250,000 and 261,959 in BioTime common shares, valued at $2.1 million

Cell Targeting Inc.

U.S. / Private Biopharma

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

BioTime Inc.

U.S. / Tools, Services, and Manufacturing

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced